LexDanaLexDanabeta
Inventor

YUNLONG ZHOU

Inventor
CN

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07DHeterocyclic compounds43%
A61KPreparations for medical, dental or toiletry purposes14%
PatentTitleYear
11,987,575Tricyclic compounds as BCR-ABL inhibitors202411,691,989Macrocyclic indoles as Mcl-1 inhibitors202311,498,928Macrocyclic spiroethers as Mcl-1 inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to ASCENTAGE PHARMA GROUP CORP LTD (3)· patent assignee history
2022–2024Patents assigned to ASCENTAGE PHARMA SUZHOU CO LTD (3)· patent assignee history
2022–2023Patents assigned to UNIV MICHIGAN REGENTS (2)· patent assignee history
2022–2024Based in CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASCENTAGE PHARMA GROUP CORP LTD32022–2024
ASCENTAGE PHARMA SUZHOU CO LTD32022–2024
UNIV MICHIGAN REGENTS22022–2023
Locations
LocationPatentsSpan
CN32022–2024